|Tested species reactivity||Human, Mouse, Rat|
|Published species reactivity||Pig, Mouse, Not Applicable|
|Host / Isotype||Rabbit / IgG|
|Immunogen||A synthetic peptide corresponding to C-terminal of human Dystrophin.|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7.4, with 1% BSA|
|Contains||0.09% sodium azide|
|Storage Conditions||4° C, do not freeze|
|Tested Applications||Dilution *|
|Immunocytochemistry (ICC)||Assay dependent|
|Immunofluorescence (IF)||Assay dependent|
|Immunohistochemistry (Frozen) (IHC (F))||1:100|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100|
|Western Blot (WB)||1 µg/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA1-21011 detects Dystrophin in Human, Mouse and Rat samples.
PA1-21011 has been successfully used in Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin) immunocytochemistry, immunofluorescence, and Western Blot procedures. Staining of formalin-fixed tissues requires boiling tissue sections in 1 mM EDTA, pH 8.0 for 10 minutes followed by cooling at room temperature for 20 minutes. Positive control of skeletal muscle suggested. Molecular weight of 427 kDa is expected.
PA1-21011 immunogen corresponds to a synthetic peptide corresponding to C-terminal of human Dystrophin.
Dystrophin is a member of the spectrin/alpha-actinin family of actin-binding, triple helix rod-containing proteins. It is absent or greatly reduced in individuals with the X-linked recessive Duchenne's muscular dystrophy disorder, as well as in mice with the mdx (murine muscular dystrophy) mutation.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
The first exon duplication mouse model of Duchenne muscular dystrophy: A tool for therapeutic development.
PA1-21011 was used in immunohistochemistry - frozen section to generate and characterize a mouse model that carries a Dmd exon 2 duplication
|Vulin A,Wein N,Simmons TR,Rutherford AM,Findlay AR,Yurkoski JA,Kaminoh Y,Flanigan KM||Neuromuscular disorders : NMD (25:827)||2015|
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice.
PA1-21011 was used in immunohistochemistry to characterize attenuation of dystrophinopathy in humans and mice by translation from a DMD exon 5 IRES that results in a functional dystrophin isoform
|Wein N,Vulin A,Falzarano MS,Szigyarto CA,Maiti B,Findlay A,Heller KN,Uhlén M,Bakthavachalu B,Messina S,Vita G,Passarelli C,Brioschi S,Bovolenta M,Neri M,Gualandi F,Wilton SD,Rodino-Klapac LR,Yang L,Dunn DM,Schoenberg DR,Weiss RB,Howard MT,Ferlini A,Flanigan KM||Nature medicine (20:992)||2014|
Variable t-tubule organization and Ca2+ homeostasis across the atria.
PA1-21011 was used in immunohistochemistry to study the effect of regional t-tubule density during cardiomyocyte Ca(2+) homeostasis
|Frisk M,Koivumäki JT,Norseng PA,Maleckar MM,Sejersted OM,Louch WE||American journal of physiology. Heart and circulatory physiology (307:H609)||2014|
Slowed relaxation and preserved maximal force in soleus muscles of mice with targeted disruption of the Serca2 gene in skeletal muscle.
PA1-21011 was used in immunohistochemistry to investigate the role of SERCAs in muscle contractile function
|Sjåland C,Lunde PK,Swift F,Munkvik M,Ericsson M,Lunde M,Boye S,Christensen G,Ellingsen Ø,Sejersted OM,Andersson KB||The Journal of physiology (589:6139)||2011|